查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947934

馬匹保健市場分析及預測（至2035年）：按類型、產品、服務、技術、應用、最終用戶、形式、材質、設備和解決方案分類

Equine Healthcare Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Form, Material Type, Device, Solutions
出版日期: | 出版商: Global Insight Services | 英文 315 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到2034年，馬匹醫療保健市場規模將從2024年的36億美元成長至65億美元，複合年成長率約為4.7%。該市場涵蓋致力於馬匹健康和福祉的產品和服務，例如藥品、疫苗、營養補充品和診斷服務。推動市場成長的因素包括馬匹疾病發生率上升、馬匹數量增加以及獸醫技術的進步。關鍵趨勢包括個人化醫療、遠端醫療服務和再生醫學。對預防保健和性能提升的重視為市場帶來了巨大的成長機會。

在獸醫學的進步和人們健康意識提升的推動下，馬匹醫療保健市場正經歷強勁成長。其中，藥品領域已成為成長最快的類別，這主要得益於疫苗和疼痛管理解決方案需求的不斷成長。營養補充品是成長速度第二快的細分市場，反映出預防醫學和提升運動表現的重要性日益凸顯。包括先進影像和檢測在內的診斷服務發展勢頭強勁，凸顯了早期疾病檢測和治療的重要性。物理治療和復健等治療服務也備受關注，以滿足老年馬匹的需求。馬術運動和休閒活動的蓬勃發展進一步推動了對全面醫療保健解決方案的需求。馬匹健康監測設備和遠距遠端醫療的創新提高了醫療服務的可近性和有效性。獸醫診所和製藥公司之間的策略合作也為市場擴張提供了支持，這些合作正在開發針對性的治療通訊協定，並推動個人化醫療保健解決方案的實現。

市場區隔
類型 治療、診斷、預防保健、復健、營養、手術、急診和健康計劃
產品 藥品、疫苗、補充品、醫療設備、手術器材、診斷設備、監測設備
服務 獸醫服務、醫療諮詢、培訓和教育、住院治療、美容、蹄鐵匠服務、復健治療
科技 遠端醫療、穿戴式科技、基因組學、生物技術、奈米技術、診斷影像技術、機器人技術
目的 馬匹外科手術、生殖健康、呼吸系統健康、肌肉骨骼健康、消化系統健康、神經系統健康、心血管健康
最終用戶 獸醫診所、動物醫院、研究機構、育種中心、賽馬馬廄、騎術中心
形式 片劑、注射劑、粉末、液體、凝膠劑、糊劑、軟膏劑
材質 生物製藥、合成材料、金屬、聚合物、陶瓷
裝置 超音波設備、 X光設備、內視鏡、核磁共振造影系統、CT掃描儀
解決方案 整合醫療保健解決方案、獨立解決方案、客製化解決方案

馬匹保健市場正經歷動態變化，市場佔有率受到創新產品發布和策略定價策略的影響。各公司紛紛推出針對馬匹需求的先進保健解決方案，這正在改變市場競爭格局。定價策略日趨複雜，反映出市場對高品質照護和治療方案的需求不斷成長。隨著對尖端解決方案的投資持續增加，這一趨勢正在推動成熟市場和新興市場的成長，這些解決方案旨在改善馬匹的健康和性能。馬匹保健產業的競爭日益激烈，主要參與者相互參考以保持競爭優勢。區域法規結構影響產品開發和市場准入，要求企業遵守嚴格的標準。北美和歐洲擁有強大的監管影響力，制定品質和安全標準。亞太和拉丁美洲等新興市場由於馬匹數量的成長和人們對馬匹健康意識的提高，正在創造盈利的市場機會。技術進步和增強競爭力的策略聯盟正在推動市場成長。

主要趨勢和促進因素：

在幾項關鍵趨勢和促進因素的推動下，馬匹醫療保健市場正經歷強勁成長。人們日益增強的動物健康和福利意識是關鍵促進因素，馬主和育種者越來越重視預防性照護和全面的健康管理。獸醫和診斷技術的進步也支持了這一轉變，這些技術提高了現有治療的品質和有效性。馬匹醫療保健領域的技術創新，例如穿戴式裝置和遠端醫療，正在改變產業格局。這些技術能夠實現即時監測和遠端會診，從而提高便利性和改善健康狀況。此外，馬術和休閒活動的日益普及也推動了對更優質醫療保健解決方案的需求，以確保競技馬匹保持最佳狀態和延長壽命。同時，對研發投入的增加正在推動新型治療方法和疫苗的問世，以應對更廣泛的馬匹疾病。獸醫機構和製藥公司之間的合作進一步促進了這一趨勢，旨在擴大獸醫可用的治療方法。馬匹保健市場預計將持續成長，為那些不斷創新並適應馬匹保健不斷變化的需求的公司帶來巨大的機會。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 治療
    • 診斷
    • 預防醫學
    • 復原
    • 營養管理
    • 外科手術
    • 緊急醫療護理
    • 健康計劃
  • 市場規模及預測：依產品分類
    • 製藥
    • 疫苗
    • 補充
    • 醫療設備
    • 手術器械
    • 診斷設備
    • 監測設備
  • 市場規模及預測：依服務分類
    • 獸醫服務
    • 醫療
    • 培訓和教育
    • 住院治療
    • 美容
    • 馬蹄鐵匠服務
    • 復健治療
  • 市場規模及預測：依技術分類
    • 遠端醫療
    • 穿戴式科技
    • 基因組學
    • 生物技術
    • 奈米科技
    • 診斷影像技術
    • 機器人技術
  • 市場規模及預測：依應用領域分類
    • 馬外科手術
    • 生殖健康
    • 呼吸系統健康
    • 肌肉骨骼健康
    • 消化系統健康
    • 神經系統健康
    • 心血管健康
  • 市場規模及預測：依最終用戶分類
    • 獸醫診所
    • 獸醫診所
    • 研究所
    • 繁殖中心
    • 賽馬馬厩
    • 馬術中心
  • 市場規模及預測：依類型
    • 藥片
    • 注射
    • 粉末
    • 液體
    • 凝膠
    • 貼上
    • 軟膏
  • 市場規模及預測：依材質
    • 生物製藥
    • 合成
    • 金屬
    • 聚合物
    • 陶瓷
  • 市場規模及預測：依設備分類
    • 超音波設備
    • X光設備
    • 內視鏡檢查
    • 核磁共振造影系統
    • CT掃描儀
  • 市場規模及預測：按解決方案分類
    • 綜合醫療保健解決方案
    • 獨立解決方案
    • 客製化解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Boehringer Ingelheim Vetmedica
  • Zoetis
  • Merck Animal Health
  • Elanco Animal Health
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol
  • Dechra Pharmaceuticals
  • Bimeda
  • Norbrook Laboratories
  • Kyoritsu Seiyaku
  • Phibro Animal Health
  • Huvepharma
  • IDEXX Laboratories
  • Neogen Corporation
  • Animalcare Group
  • Immu Cell Corporation
  • Biogenesis Bago
  • Vetanco
  • Ourofino Saude Animal

第9章：關於我們

簡介目錄
Product Code: GIS27045

Equine Healthcare Market is anticipated to expand from $3.6 billion in 2024 to $6.5 billion by 2034, growing at a CAGR of approximately 4.7%. The Equine Healthcare Market encompasses products and services dedicated to the health and well-being of horses, including pharmaceuticals, vaccines, nutritional supplements, and diagnostic services. This market is driven by the rising prevalence of equine diseases, increasing horse ownership, and advancements in veterinary technology. Key trends include personalized medicine, telehealth services, and regenerative therapies. The focus on preventive care and performance enhancement offers significant growth opportunities.

The Equine Healthcare Market is experiencing robust growth, propelled by rising awareness and advancements in veterinary care. Within this market, the pharmaceuticals segment emerges as the top-performing category, driven by increased demand for vaccines and pain management solutions. Nutritional supplements follow as the second highest-performing sub-segment, reflecting a growing emphasis on preventive care and performance enhancement. Diagnostic services, including advanced imaging and laboratory testing, are gaining momentum, highlighting the importance of early disease detection and treatment. Therapeutic services, such as physiotherapy and rehabilitation, are also witnessing significant traction, catering to the needs of aging equine populations. The surge in equine sports and leisure activities further fuels demand for comprehensive healthcare solutions. Innovations in equine health monitoring devices and telemedicine are enhancing care accessibility and efficacy. The market's expansion is supported by strategic collaborations between veterinary clinics and pharmaceutical companies, fostering the development of targeted treatment protocols and tailored healthcare solutions.

Market Segmentation
TypeTherapeutics, Diagnostics, Preventive Care, Rehabilitation, Nutrition, Surgery, Emergency Care, Wellness Programs
ProductPharmaceuticals, Vaccines, Supplements, Medical Devices, Surgical Instruments, Diagnostic Equipment, Monitoring Devices
ServicesVeterinary Services, Consultation, Training and Education, Boarding, Grooming, Farrier Services, Rehabilitation Therapy
TechnologyTelemedicine, Wearable Technology, Genomics, Biotechnology, Nanotechnology, Imaging Technology, Robotics
ApplicationEquine Surgery, Reproductive Health, Respiratory Health, Musculoskeletal Health, Gastrointestinal Health, Neurological Health, Cardiovascular Health
End UserVeterinary Clinics, Animal Hospitals, Research Institutes, Breeding Centers, Racing Stables, Equestrian Centers
FormTablets, Injections, Powders, Liquids, Gels, Pastes, Ointments
Material TypeBiologicals, Synthetics, Metals, Polymers, Ceramics
DeviceUltrasound Machines, X-Ray Machines, Endoscopes, MRI Machines, CT Scanners
SolutionsIntegrated Healthcare Solutions, Standalone Solutions, Custom Solutions

The Equine Healthcare Market is experiencing a dynamic shift, with market share being influenced by innovative product launches and strategic pricing approaches. Companies are introducing advanced healthcare solutions tailored to equine needs, which are reshaping competitive dynamics. Pricing strategies are becoming more sophisticated, reflecting the increasing demand for premium care and treatment options. This trend is driving growth in both established and emerging markets, as stakeholders invest in cutting-edge solutions to enhance equine health and performance. Competition within the equine healthcare sector is intensifying, with key players benchmarking against each other to maintain a competitive edge. Regulatory frameworks across regions impact product development and market entry, necessitating compliance with stringent standards. North America and Europe lead in regulatory influence, setting benchmarks for quality and safety. Emerging markets in Asia-Pacific and Latin America present lucrative opportunities, driven by rising equine populations and increasing awareness of equine health. The market is poised for growth, with technological advancements and strategic partnerships enhancing competitive positioning.

Geographical Overview:

The equine healthcare market is witnessing robust growth across various regions, each presenting unique opportunities. North America leads, driven by a high prevalence of equine diseases and substantial investments in veterinary healthcare. The region's advanced healthcare infrastructure and a strong equestrian culture further bolster market expansion. Europe follows, with countries like Germany and France investing heavily in equine health research and equine welfare initiatives. The Asia Pacific region is experiencing rapid growth, propelled by increasing awareness of equine health and rising disposable incomes. Countries such as China and India are emerging as key markets, with growing equestrian sports and leisure activities. Latin America and the Middle East & Africa are also showing potential, with increasing government support for veterinary services and equine welfare. Brazil and the UAE are notable emerging markets, recognizing the importance of equine healthcare in supporting their thriving equestrian industries.

Tariffs and geopolitical tensions are significantly impacting the Equine Healthcare Market, especially in East Asia. Japan and South Korea are navigating trade barriers by enhancing local production capabilities and fostering innovation in equine pharmaceuticals and diagnostics. China, amidst geopolitical strains, is investing in self-sufficiency and expanding its equine healthcare infrastructure. Taiwan, while a pivotal player in high-tech veterinary equipment, faces geopolitical vulnerabilities. The global equine healthcare market is witnessing steady growth, driven by rising equine sports and leisure activities. By 2035, market evolution will hinge on strategic partnerships and supply chain resilience. Middle East conflicts are indirectly influencing the market, as fluctuations in energy prices affect transportation and manufacturing costs, necessitating adaptive strategies in these Asian markets.

Key Trends and Drivers:

The equine healthcare market is experiencing robust growth, propelled by several key trends and drivers. Rising awareness of animal health and welfare is a primary driver, as owners and breeders increasingly prioritize preventative care and comprehensive health management for their horses. This shift is supported by advancements in veterinary medicine and diagnostics, which are enhancing the quality and efficacy of treatments available. Technological innovations in equine healthcare, such as wearable devices and telemedicine, are transforming the industry landscape. These technologies enable real-time monitoring and remote consultations, providing convenience and improved health outcomes. Additionally, the growing popularity of equestrian sports and recreational activities is fueling demand for superior healthcare solutions to ensure peak performance and longevity of equine athletes. Moreover, increased investment in research and development is fostering the introduction of novel therapeutics and vaccines, addressing a broader range of equine diseases. This trend is further driven by collaborations between veterinary institutions and pharmaceutical companies, aiming to expand the therapeutic arsenal available to veterinarians. The equine healthcare market is poised for sustained growth, with significant opportunities for companies that innovate and adapt to the evolving needs of equine health management.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Form
  • 2.8 Key Market Highlights by Material Type
  • 2.9 Key Market Highlights by Device
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Therapeutics
    • 4.1.2 Diagnostics
    • 4.1.3 Preventive Care
    • 4.1.4 Rehabilitation
    • 4.1.5 Nutrition
    • 4.1.6 Surgery
    • 4.1.7 Emergency Care
    • 4.1.8 Wellness Programs
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Pharmaceuticals
    • 4.2.2 Vaccines
    • 4.2.3 Supplements
    • 4.2.4 Medical Devices
    • 4.2.5 Surgical Instruments
    • 4.2.6 Diagnostic Equipment
    • 4.2.7 Monitoring Devices
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Veterinary Services
    • 4.3.2 Consultation
    • 4.3.3 Training and Education
    • 4.3.4 Boarding
    • 4.3.5 Grooming
    • 4.3.6 Farrier Services
    • 4.3.7 Rehabilitation Therapy
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Telemedicine
    • 4.4.2 Wearable Technology
    • 4.4.3 Genomics
    • 4.4.4 Biotechnology
    • 4.4.5 Nanotechnology
    • 4.4.6 Imaging Technology
    • 4.4.7 Robotics
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Equine Surgery
    • 4.5.2 Reproductive Health
    • 4.5.3 Respiratory Health
    • 4.5.4 Musculoskeletal Health
    • 4.5.5 Gastrointestinal Health
    • 4.5.6 Neurological Health
    • 4.5.7 Cardiovascular Health
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Veterinary Clinics
    • 4.6.2 Animal Hospitals
    • 4.6.3 Research Institutes
    • 4.6.4 Breeding Centers
    • 4.6.5 Racing Stables
    • 4.6.6 Equestrian Centers
  • 4.7 Market Size & Forecast by Form (2020-2035)
    • 4.7.1 Tablets
    • 4.7.2 Injections
    • 4.7.3 Powders
    • 4.7.4 Liquids
    • 4.7.5 Gels
    • 4.7.6 Pastes
    • 4.7.7 Ointments
  • 4.8 Market Size & Forecast by Material Type (2020-2035)
    • 4.8.1 Biologicals
    • 4.8.2 Synthetics
    • 4.8.3 Metals
    • 4.8.4 Polymers
    • 4.8.5 Ceramics
  • 4.9 Market Size & Forecast by Device (2020-2035)
    • 4.9.1 Ultrasound Machines
    • 4.9.2 X-Ray Machines
    • 4.9.3 Endoscopes
    • 4.9.4 MRI Machines
    • 4.9.5 CT Scanners
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Integrated Healthcare Solutions
    • 4.10.2 Standalone Solutions
    • 4.10.3 Custom Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Form
      • 5.2.1.8 Material Type
      • 5.2.1.9 Device
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Form
      • 5.2.2.8 Material Type
      • 5.2.2.9 Device
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Form
      • 5.2.3.8 Material Type
      • 5.2.3.9 Device
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Form
      • 5.3.1.8 Material Type
      • 5.3.1.9 Device
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Form
      • 5.3.2.8 Material Type
      • 5.3.2.9 Device
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Form
      • 5.3.3.8 Material Type
      • 5.3.3.9 Device
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Form
      • 5.4.1.8 Material Type
      • 5.4.1.9 Device
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Form
      • 5.4.2.8 Material Type
      • 5.4.2.9 Device
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Form
      • 5.4.3.8 Material Type
      • 5.4.3.9 Device
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Form
      • 5.4.4.8 Material Type
      • 5.4.4.9 Device
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Form
      • 5.4.5.8 Material Type
      • 5.4.5.9 Device
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Form
      • 5.4.6.8 Material Type
      • 5.4.6.9 Device
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Form
      • 5.4.7.8 Material Type
      • 5.4.7.9 Device
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Form
      • 5.5.1.8 Material Type
      • 5.5.1.9 Device
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Form
      • 5.5.2.8 Material Type
      • 5.5.2.9 Device
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Form
      • 5.5.3.8 Material Type
      • 5.5.3.9 Device
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Form
      • 5.5.4.8 Material Type
      • 5.5.4.9 Device
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Form
      • 5.5.5.8 Material Type
      • 5.5.5.9 Device
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Form
      • 5.5.6.8 Material Type
      • 5.5.6.9 Device
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Form
      • 5.6.1.8 Material Type
      • 5.6.1.9 Device
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Form
      • 5.6.2.8 Material Type
      • 5.6.2.9 Device
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Form
      • 5.6.3.8 Material Type
      • 5.6.3.9 Device
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Form
      • 5.6.4.8 Material Type
      • 5.6.4.9 Device
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Form
      • 5.6.5.8 Material Type
      • 5.6.5.9 Device
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Boehringer Ingelheim Vetmedica
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Zoetis
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Merck Animal Health
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Elanco Animal Health
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Ceva Sante Animale
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Virbac
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Vetoquinol
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Dechra Pharmaceuticals
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Bimeda
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Norbrook Laboratories
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Kyoritsu Seiyaku
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Phibro Animal Health
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Huvepharma
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 IDEXX Laboratories
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Neogen Corporation
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Animalcare Group
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Immu Cell Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Biogenesis Bago
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Vetanco
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Ourofino Saude Animal
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us